WHO ICTRP trial

A research study to find out whether steroids given by mouth, an injection…

ISRCTN10535105 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN10535105
Public title A research study to find out whether steroids given by mouth, an injection through the ear drum, or a combination of both treatments is best at improving hearing after unexplained sudden hearing loss.
Scientific title A randomised controlled trial of STeroid Administration Routes For Idiopathic Sudden sensorineural Hearing loss: The STARFISH Trial
Primary sponsor University of Birmingham
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Interventional
Phase Phase III
Countries England;Northern Ireland;Scotland;United Kingdom;Wales
Conditions Idiopathic sudden sensorineural hearing loss Ear, Nose and Throat A sudden loss of hearing (over 3 days or less), due to inner ear damage, with no obvious cause
Interventions Oral steroid (Prednisolone) 1mg/Kg/day up to 60mg/day for 7 days or Intratympanic steroid (Dexamethasone) three intratympanic injections 3.3mg/ml or 3.8mg/ml spaced 7±2 days apart or Combined oral (Prednisolone) and intratympanic…
Registration date Feb 12, 2022
Target size 525
Secondary IDs 2022-000085-17;Nil known;RG_21-145, IRAS 1004878, CPMS 53517
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations